Torno Capital »

Apellis Pharmaceuticals shares owned by Torno Capital

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Torno Capital from 13F filings

Historical chart of Torno Capital investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Torno Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Torno Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.0M 18k 59.86

More positions owned by Torno Capital

Sprott Fds Tr Uranium Miners E Put Option (URNM)
Spotify Technology S A SHS Put Option (SPOT)
Alphabet Cap Stk Cl A (GOOGL)
Global X Fds Global X Uranium Put Option (URA)
Ishares Msci Sth Kor Etf Put Option (EWY)
Colgate-Palmolive Company Put Option (CL)
Caterpillar Call Option (CAT)
BlackRock Call Option (BLK)
Booz Allen Hamilton Hldg Cor Cl A Call Option (BAH)
United States Stl Corp New Com Put Option (X)
Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Incyte Corporation Call Option (INCY)
Realty Income Call Option (O)
Rio Tinto Sponsored Adr Call Option (RIO)
Regeneron Pharmaceuticals Put Option (REGN)

View all positions for Torno Capital

Top funds holding Apellis Pharmaceuticals

Wellington Management Company
EcoR1 Capital
venBio Select Advisor
Vanguard Group
Jennison Associates
Octagon Capital Advisors
Jpmorgan Chase & Co
T. Rowe Price Associates
Assenagon Asset Management
Logos Global Management
Boxer Capital
Artal Group
Citadel Advisors
Caption Management
Norges Bank Investment Management

View all funds holding Apellis Pharmaceuticals